—
C+
C+ The full Closelooknet — membership. Open the C+ overview

AstraZeneca PLC (AZN.L) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for AZN.L, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index AI Users — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

AI Users · as of 2026-10-23

DayWeekMonth3 months
AZN.L−1.2%+3.0%+3.4%+0.2%
Research, Design & Development−1.0%+3.0%+5.4%—
AI Users−1.2%+1.1%+6.6%—

Against the index: 1.9 pts ahead on the week, 3.2 pts behind on the month; against its Research, Design & Development sleeve 2.0 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 46/100 · S&P 500 fund at 46, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-23
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 81th percentile of the window, -14.3% over 20 sessions. Factor regime → 2026-10-23
  • Sovereign pressure Index -1.16 · down 1.91 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-23
Who it is priced against AI Users · Research, Design & Development · 3 names with week and year-to-date

Peer group

AI Users · Research, Design & Development

Compared against AZN.L on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Dividends and capital return trailing yield 1.86%, semi-annual · last 79.50 GBP on 2026-08-06

Dividends and capital return

What AZN.L pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 239 GBP per share · a 1.86% yield on the 2026-10-23 close 2 distributions, paid twice a year 2026-10-23
  • Change on the year −2.3% against the prior twelve months prior twelve months 245 GBP per share
  • Last distribution 79.50 GBP per share as the price series records it, within days of the ex-date 2026-08-06
  • By calendar year 2025: 245 GBP (partial) · 2026: 239 GBP to date first distribution recorded in the three-year window: 2025-02-20
  • Dividends paid, FY2025 4.97 bn GBX 25% of earnings
  • Share count −0.1% in FY2025
  • Capital returned 4.97 bn GBX · 57% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

About AstraZeneca PLC

AstraZeneca PLC (AZN.L) trades on the LSE exchange in UK.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-10-24

Quick answers

What is AstraZeneca PLC (AZN.L)?

AstraZeneca PLC trades as AZN.L on the LSE exchange (UK) in the Closelooknet research universe, as of the registry build of 2026-10-24.

Is AZN.L in a Closelooknet index?

Not currently — AstraZeneca PLC is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-24.

Where does AZN.L trade against its moving averages?

Recovery attempt under the 200-day: Trades +5.3% vs the 50-day and -4% vs the 200-day average, 17.1% below the 52-week high and +30.5% off the 52-week low; a death cross printed 75 sessions ago. Computed from daily closes. As of 2026-10-23 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is AZN.L doing against its Closelooknet index?

Over the past month AstraZeneca PLC is +3.4% against +6.6% for the AI Users — 3.2 points behind its index, as of 2026-10-23. Its Research, Design & Development sleeve is +5.4% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does AstraZeneca PLC compare with its peers?

Against its peer group (AI Users · Research, Design & Development), AstraZeneca PLC (AZN.L) sits 17.1% below its 52-week high, 5.3% above its 50-day average; Eli Lilly and Company (LLY) is 3.6% below, Roche Holding AG (ROP.SW) is 1.0% below, Natera Inc (NTRA) is 7.6% below. Put any of them next to AZN.L in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

Does AstraZeneca PLC pay a dividend?

AstraZeneca PLC has paid 239 GBP per share over the last twelve months, paid twice a year, a trailing yield of 1.86% on the 2026-10-23 close; the last distribution recorded in the price series was 79.50 GBP on 2026-08-06. In fiscal 2025 the company paid 4.97 bn GBX in dividends, 57% of that year’s free cash flow. The share count fell 0.1% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for AZN.L, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.